What does DR. K. BOEL do?

DR. K. BOEL is a specialist medical practice in Izegem. Private Limited, started on 9 January 2007, 2 establishments.

What is the address of DR. K. BOEL?

The registered office of DR. K. BOEL is located at Middenweg 7, 8870 Izegem.

Is DR. K. BOEL still active?

Yes. According to the CBE (19 September 2026) DR. K. BOEL is active, legal situation “Normale toestand”, started on 9 January 2007.

Is DR. K. BOEL registered on Peppol?

Yes, DR. K. BOEL is registered on the Peppol network with ID 0208:0886219120.

What is the enterprise number of DR. K. BOEL?

The enterprise number of DR. K. BOEL is BE0886219120.

When was DR. K. BOEL founded?

DR. K. BOEL was founded on 9 January 2007.

Who are the directors of DR. K. BOEL?

According to the 2024 annual accounts, the directors of DR. K. BOEL are: Kristien Boel.

Is DR. K. BOEL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 January 2007; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. K. BOEL make in 2024?

DR. K. BOEL posted a profit after taxes of € 301,583 in financial year 2024.

What is the revenue of DR. K. BOEL?

As a small company, DR. K. BOEL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 440,234.

DR. K. BOEL (Private Limited) - Izegem - BE0886219120

Dossier DR. K. BOEL, printed on 19 September 2026 from databakkes.be/en/0886219120/dr-k-boel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DR. K. BOEL from Izegem, company number BE0886219120, closed financial year 2024 with a result of € 301,583 after tax. For that financial year DR. K. BOEL recorded a gross margin of € 440,234 and equity of € 2.3 million. Compared with financial year 2023, the result moved from € 135,431 to € 301,583. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 26, 2025.

What it is worth Growing

€ 2.3 million

▲ 15% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 301,583

▲ 123% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 573,977

▼ 16% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,500 paid out

0 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 15,890

▲ 111% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 121

▼ 52% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,803

▲ 34% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,823

▲ € 33,817 vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 326,053 Gross margin 2021: € 326,053 First fiscal year in the series	€ 362,191 Gross margin 2022: € 362,191 ▲ 11% vs 2021 (€ 326,053) Favourable step	€ 382,000 Gross margin 2023: € 382,000 ▲ 5% vs 2022 (€ 362,191) Favourable step	€ 440,234 Gross margin 2024: € 440,234 ▲ 15% vs 2023 (€ 382,000) Favourable step	▲ 15%
Profit after taxes	€ 210,135 Profit after taxes 2021: € 210,135 First fiscal year in the series	€ 228,570 Profit after taxes 2022: € 228,570 ▲ 9% vs 2021 (€ 210,135) Favourable step	€ 135,431 Profit after taxes 2023: € 135,431 ▼ 41% vs 2022 (€ 228,570) Unfavourable step	€ 301,583 Profit after taxes 2024: € 301,583 ▲ 123% vs 2023 (€ 135,431) Favourable step	▲ 123%
Equity	€ 1,710,048 Equity 2021: € 1,710,048 First fiscal year in the series	€ 1,937,118 Equity 2022: € 1,937,118 ▲ 13% vs 2021 (€ 1,710,048) Favourable step	€ 1,981,048 Equity 2023: € 1,981,048 ▲ 2% vs 2022 (€ 1,937,118) Favourable step	€ 2,281,131 Equity 2024: € 2,281,131 ▲ 15% vs 2023 (€ 1,981,048) Favourable step	▲ 15%
Total debts	€ 148,639 Total debts 2021: € 148,639 First fiscal year in the series	€ 135,254 Total debts 2022: € 135,254 ▼ 9% vs 2021 (€ 148,639) Favourable step	€ 120,170 Total debts 2023: € 120,170 ▼ 11% vs 2022 (€ 135,254) Favourable step	€ 159,403 Total debts 2024: € 159,403 ▲ 33% vs 2023 (€ 120,170) Unfavourable step	▲ 33%
Cash	€ 484,863 Cash 2021: € 484,863 First fiscal year in the series	€ 619,108 Cash 2022: € 619,108 ▲ 28% vs 2021 (€ 484,863) Favourable step	€ 684,396 Cash 2023: € 684,396 ▲ 11% vs 2022 (€ 619,108) Favourable step	€ 573,977 Cash 2024: € 573,977 ▼ 16% vs 2023 (€ 684,396) Unfavourable step	▼ 16%
Land & buildings	€ 466,723 Land & buildings 2021: € 466,723 First fiscal year in the series	€ 453,107 Land & buildings 2022: € 453,107 ▼ 3% vs 2021 (€ 466,723) Unchanged	-	€ 7,619 Land & buildings 2024: € 7,619 First fiscal year in the series
Retained profit	€ 1,635,048 Retained profit 2021: € 1,635,048 First fiscal year in the series	€ 1,862,118 Retained profit 2022: € 1,862,118 ▲ 14% vs 2021 (€ 1,635,048) Favourable step	€ 1,906,048 Retained profit 2023: € 1,906,048 ▲ 2% vs 2022 (€ 1,862,118) Favourable step	€ 2,206,131 Retained profit 2024: € 2,206,131 ▲ 16% vs 2023 (€ 1,906,048) Favourable step	▲ 16%
Dividend	€ 1,500 Dividend 2021: € 1,500 First fiscal year in the series	€ 1,500 Dividend 2022: € 1,500 Unchanged (€ 1,500) Unchanged	€ 91,500 Dividend 2023: € 91,500 ▲ € 90,000 vs 2022 (€ 1,500) Unchanged	€ 1,500 Dividend 2024: € 1,500 ▼ 98% vs 2023 (€ 91,500) Unchanged	▼ 98%
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 255 Bank debt 2023: € 255 Unchanged (€ 0) Unfavourable step	€ 121 Bank debt 2024: € 121 ▼ 52% vs 2023 (€ 255) Favourable step	▼ 52%
Balance sheet total	€ 1,858,687 Balance sheet total 2021: € 1,858,687 First fiscal year in the series	€ 2,072,372 Balance sheet total 2022: € 2,072,372 ▲ 11% vs 2021 (€ 1,858,687) Unchanged	€ 2,101,219 Balance sheet total 2023: € 2,101,219 ▲ 1% vs 2022 (€ 2,072,372) Unchanged	€ 2,440,534 Balance sheet total 2024: € 2,440,534 ▲ 16% vs 2023 (€ 2,101,219) Unchanged	▲ 16%

Key figures of DR. K. BOEL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR. K. BOEL?

What happened at DR. K. BOEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 26, 2025 New annual accounts for financial year 2024: profit of € 301,583 (▲ 123% vs 2023). filed late Source: NBB ↗
Jan 9, 2007 New establishment in Izegem. KBO
Jan 9, 2007 New establishment in Menen. KBO
Jan 9, 2007 Start of the company according to the CBE. KBO
2007 Kristien Boel became a director. NBB

In short

From € 210,135 profit in 2021 to € 301,583 profit in 2024.

Paid € 401,469 in corporate taxes since 2021.

Best year ever: 2024, with € 301,583 profit.

Paid out € 96,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. K. BOEL? We notify you, reason included.

Follow DR. K. BOEL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kristien Boel

DR. K. BOEL

Behind DR. K. BOEL is Kristien Boel.

See the full network in the app

Directors

According to the 2024 annual accounts

Kristien Boel

Bestuurder

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Middenweg 7

8870 Izegem

2.302.820.283

Oude Leielaan 6

8930 Menen

Active since 9 January 2007

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VANDENBROUCKE FRANK UROLOGIE

€ 295,308 gross margin · 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0886.219.120

VAT number

BE 0886.219.120

Registered office

Middenweg 7, 8870 Izegem

Names & denominations

DR. K. BOEL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 January 2007

Peppol

Active · Active since 27 Mar 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. K. BOEL

Financials

What happened to DR. K. BOEL?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions